|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6950 EUR | +14.50% |
|
+10.86% | -52.86% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-11 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.18% | -2.90% | -1.20% | +13.16% | +21.60% | +60.28% | +21.90% | +69.58% | +121.30% | 316B | |
| -1.50% | -1.24% | +0.35% | +29.62% | +16.88% | +32.81% | -10.47% | -23.92% | +44.89% | 73.28B | |
| +1.17% | -0.26% | +4.76% | +28.90% | +23.67% | +38.74% | +96.25% | +107.35% | +716.78% | 9.87B | |
| +0.10% | -9.19% | -10.27% | +2.55% | -2.87% | -4.48% | -7.78% | -28.34% | +47.51% | 8.15B | |
| +1.79% | +0.38% | -7.42% | -19.64% | -35.96% | -16.96% | -17.13% | -35.38% | - | 4.38B | |
| +1.63% | +5.80% | +6.25% | -17.35% | -33.45% | -33.57% | +6.86% | +39.89% | +81.77% | 3.91B | |
| +3.58% | +0.05% | -20.22% | +11.98% | +24.57% | -16.91% | +18.28% | -36.16% | - | 3.62B | |
| -5.98% | -9.39% | -9.99% | -11.06% | -12.98% | +16.73% | +34.40% | +59.12% | +93.77% | 2.51B | |
| -0.82% | +6.62% | +1.85% | -11.62% | -12.68% | -2.59% | -3.15% | +71.09% | - | 2.24B | |
| -1.68% | +1.86% | -1.68% | -8.55% | -13.17% | -23.34% | -15.75% | -9.77% | -41.90% | 1.74B | |
| +3.74% | -1.10% | -6.47% | -14.18% | -8.01% | -26.01% | +27.27% | -34.13% | - | 1.76B | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | |
| -16.69% | -4.39% | -9.18% | -40.35% | -39.62% | +44.49% | +35.49% | +18.09% | +439.50% | 1.17B | |
| +1.53% | -1.78% | +22.21% | +51.96% | +171.02% | +218.49% | +1,597.41% | +708.29% | - | 1.26B | |
| +4.05% | +7.43% | -11.50% | -28.96% | -16.34% | -48.57% | -18.86% | - | - | 1.19B | |
| +1.17% | -9.92% | -5.22% | -10.44% | -16.02% | -12.25% | +11.25% | +68.46% | +59.71% | 1.02B | |
| +5.43% | -7.25% | -34.91% | -13.76% | 0.00% | -16.86% | +66.67% | -11.91% | - | 1B | |
| +0.73% | +5.49% | +2.29% | -16.46% | -19.51% | -36.30% | -73.39% | -82.45% | - | 930M | |
| +0.41% | +3.12% | -0.20% | -9.67% | -10.97% | -42.44% | -7.30% | -45.48% | -65.43% | 892M | |
| Average | -0.06% | -0.21% | -4.48% | -3.55% | +2.01% | +7.29% | +97.89% | +49.08% | +149.79% | 22.98B | |
| Weighted average by Cap. | +0.22% | -1.94% | -1.25% | +14.64% | +18.58% | +49.78% | +21.12% | +50.76% | +119.66% |
- Stock Market
- Stocks
- AB Stock
- A8D Stock
- Sector AB Science
Select your edition
All financial news and data tailored to specific country editions
